What do we know about blood clots and the AstraZeneca Covid vaccine?
The rollout of the Oxford-AstraZeneca Covid vaccine hasn’t been straightforward. After weathering early questions about its efficacy, there has been a series of rare blood clotting incidents, resulting in several deaths overseas. As authorities investigate whether the vaccine is responsible, some countries have paused their programs while others, such as the UK and Australia, are forging ahead. Medical editor Melissa Davey explores what we know about the risks and benefits
You can also read:
- Should Australians be worried about two countries putting AstraZeneca vaccine rollout on ice?, by Melissa Davey
- AstraZeneca Covid vaccine: weighing up the risks and rewards, by Sarah Bosely
Support The Guardian
The Guardian is editorially independent. And we want to keep our journalism open and accessible to all. But we increasingly need our readers to fund our work.
Support The Guardian